JESSICA ARBOGAST: Open Payments
NPI 1154721108 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,296 in 48 payments from 5 companies in 2025. Trend: 2023 $429 · 2024 $8,586 · 2025 $6,296
Speaker / faculty: $3,550Food & beverage: $1,524Travel & lodging: $1,221
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 17 | $5,275 |
| ABBVIE INC. | 18 | $450 |
| Braeburn Inc. | 5 | $291 |
| Alkermes, Inc. | 6 | $233 |
| Indivior Inc. | 2 | $46 |
Products named: Epclusa, BRIXADI, MAVYRET, VIVITROL, VRAYLAR, Biktarvy, SUBLOCADE, ARISTADA.
Industry payments across UT — which companies pay providers there.
